Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 6 of 55, showing 5 Applications out of 272 total, starting on record 26, ending on 30

# Protocol No Study Title Investigator(s) & Site(s) Application Status

26.

ECCT/15/01/03   Simplifying ShangRing Circumcision for Men and Boys
    Simplifying the Shang Ring Technique for Circumcision of Men and Boys   
Principal Investigator(s)
1. Mark Barone
Site(s) in Kenya
1. Homa Bay Level IV hospital (Homa Bay county)
2. Vipingo Health Centre (Kilifi county)
 
Trial Status Completed
Protocol Date 09-01-2015
View

27.

ECCT/13/08/06  
    Management of myocardial injury After NoncArdiac surgGEry (MANAGE) Trial   
Principal Investigator(s)
1. GERALD OCHIENG\' YONGA
2. LEONARD MZEE NGUNGA
Site(s) in Kenya
Aga Khan University Hospital, Nairobi
 
Trial Status Recruiting
Protocol Date 30-11-2012
View

28.

ECCT/16/05/02   Monitoring Pre-exposure Prophylaxis for Young Adult women (MPYA)
    Next generation real-time monitoring for PrEP adherence in young Kenyan women   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Partners Study Clinic (Partners in Health Research and Development) (Kiambu county)
2. Partners in Prevention, Kisumu Site (Kisumu county)
 
Trial Status Analysing
Protocol Date 19-04-2016
View

29.

ECCT/16/12/03   The Partners Scale-Up Project
    An implementation project to scale-up delivery of antiretroviral-based HIV-1 prevention among Kenyan HIV-1 serodiscordant couples   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Level 5 Hospital, Ruiru Sub-County Hospital, Kiambu County Hospital, Kikuyu PCEA Hospital (Kiambu county)
2. Coptic Hospital, Mbagathi Hospital, St. Mary\'s Hospital, Pumwani Maternity Hospital (Nairobi City county)
3. Nyeri PGH, Karatina Sub-County Hospital, (Nyeri county)
4. Kerugoya County Hospital (Kirinyaga county)
5. Murang\'a County Hospital (Murang\'a county)
 
Trial Status In follow-up
Protocol Date 24-10-2016
View

30.

ECCT/16/11/02   IMPAACT P1093
    Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and AdolescentsPhase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents   
Principal Investigator(s)
1. Lucy Koech
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITUTE/WALTER REED PROJECT HIV PROGRAME
 
Trial Status In follow-up
Protocol Date 13-04-2016
View